BLINAtumomab After R-CHOP Debulking Therapy for Patients With Richter Transformation

Clinical trial NCT03931642 · COMPLETED

Trial details

NCT number: NCT03931642
Sponsor: French Innovative Leukemia Organisation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Richter Syndrome

Start date: 2019-07-05
Primary completion: 2021-10-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.